DOCSLIB.ORG

Dasami Lab Pvt. Ltd. Sy.No

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dasami Lab Pvt. Ltd. Sy.No DASAMI LAB PVT. LTD. SY.NO. 404, 405, 407, 408, 409 AND 410, VELIMINEDU VILLAGE, CHITYAL MANDAL, NALGONDA DISTRICT, TELANGANA RISK ASSESSMENT REPORT SUBMITTED TO MINISTRY OF ENVIRONMENT, FOREST AND CLIMATE CHANGE GOVERNMENT OF INDIA INDIRA PARYAVARAN BHAWAN, JOR BAGH ROAD, NEW DELHI Dasami Lab Pvt. Ltd. Environmental Impact Assessment Report 7.0 RISK ADDITIONAL STUDIES 7.0 Introduction This chapter presents the risk assessment study results for the plant operations, transport and storage of raw materials, and identifies maximum credible accident scenarios to draw the emergency management plan addressing various credible scenarios identified. 7.1. Objectives and Scope The production of Synthetic Organic chemicals (bulk drug and intermediates) involves usage of many chemicals which are both hazardous and toxic in nature. The risks associated with the chemical industry are commensurate with their rapid growth and development. Apart from their utility, chemicals have their own inherent properties and hazards. Some of them can be flammable, explosive, toxic or corrosive etc. The whole lifecycle of a chemical should be considered when assessing its dangers and benefits. In order to ensure the health and safety of persons at or near the facilities, Govt. has approved some regulations. The regulation requires Employers to consult with employees in relation to: - Identification of major hazards and potential major accidents - Risk assessment - Adoption of control measures - Establishment and implementation of a safety management system - Development of the safety report The involvement of the employees in identification of hazards and control measures enhances their awareness of these issues and is critical to the achievement of safe operation in practice. In order to comply with regulatory authorities, M/s Dasami Lab Pvt. Ltd., have entrusted Team Labs and Consultants, Hyderabad to review and prepare Hazard analysis and Risk assessment for their facility along with an approach to on-site emergency preparedness plan as required under the acts and rules. (Manual on emergency preparedness for chemical hazards, MOEF, New Delhi). In this endeavor, the methodology adopted is based on; 7-1 Team Labs and Consultants Dasami Lab Pvt. Ltd. Environmental Impact Assessment Report visualizing various probable undesirable events which lead to major accidents detailed and systematic assessment of the risk associated with each of those hazards, including the likelihood and consequences of each potential major accident event; and identifying the technical and other control measures that are necessary to reduce that risk to a level that is as low as reasonably practicable The strategy to tackle such emergencies, in-depth planning and person(s) or positional responsibilities of employees for implementation and coordination of timely and effective response measures are described in onsite detail in Emergency Plan. 7.2 Project Details The plant site is located at Survey No. 404, 405, 407, 408, 409 & 410, Veliminedu Village, Chityal Mandal, Nalgonda District, Telangana State. 43.875 acres of site is additionally acquired for the expansion to the existing 7.125 acres. The total site area for expansion is 51 acres. The site is located at the intersection of 17°13'27" (N) latitude and 79° 2'45" (E) longitude. The plant site elevation above mean sea level (MSL) is in the range of 329 - 338 m. The plant site is surrounded by open agricultural land in east and south directions, proposed site of Actero Pharma Pvt. Ltd., in west direction and Pittampalli village road connecting national highway in north direction. The nearest habitation from the plant is Pittampalli village located at a distance of 2.2 km in southwest direction. The main approach road NH-9 with pittamapalli village is adjacent to site in north direction. National Highway 9 - Hyderabad - Vijayawada is at a distance of 0.5 km in north direction. The nearest town Chityal is at a distance of 8.3 km in northeast direction. The nearest railway station Ramannapet is at a distance of 7.6 km in northeast direction and nearest airport is Rajiv Gandhi International Airport (Hyderabad) located at a distance of 65 km in northwest direction. Seasonal nala Chinna Vagu is flowing from northwest to southeast direction at a distance of 6.5 km in southwest direction. There are two reserve forests in the impact area of 10 km radius of the study area. Chityal RF at a distance of 6.0 7-2 Team Labs and Consultants Dasami Lab Pvt. Ltd. Environmental Impact Assessment Report km in east direction, Shivanenigudem RF at a distance of 9.0 km in northeast direction. There is no national park, wildlife sanctuary, ecologically sensitive area, biosphere reserve, tiger reserve, elephant reserve, critically polluted areas and interstate boundary within 10 km radius of the site. The manufacturing capacities of the proposed bulk drug and intermediates after expansion is presented in Table 7.1 and Table 7.2 Chemical inventory is presented in Table 7.3 Table 7.1 Manufacturing Capacity – After Expansion S.No Name of Product CAS No. Capacity TPM Kg/day 1 Amlodipine Besylate 111470-99-6 20 666.7 2 Aprimilast 608141-41-9 3 100 3 Bocepravir 394730-60-0 6 200 4 Bupropion HCl 31677-93-7 20 666.7 5 Carvedilol 72956-09-3 30 1000 6 Clopidogrel Hydrogen Bisulfate 135046-48-9 10 333.33 7 Colisevelam 182815-44-7 6 200 8 Dalfampridine 45498-20-2 17 566.7 9 Dex lansoprazole 138530-94-6 5 166.67 10 Divalproex Sodium 76584-70-8 15 500 11 Drotaverine HCl 985-12-6 3 100 12 Duloxetine HCl 136434-34-9 15 500 13 Esli Carbazapine 236395-14-5 2 66.7 14 Fexofenadine HCl 153439-40-8 10 333.3 15 Glimepride 93479-97-1 3 100 16 Lansoprazole 103577-45-3 8 266.67 17 Lomitapide 202914-84-9 2 66.7 18 Mesalamine 89-57-6 7 233.33 19 Nebumitone 42924-53-8 10 333.33 20 Omeprazole 73590-58-6 5 166.7 21 Piperquine Phosphate 4085-31-8 5 166.7 22 posacanazole 171228-49-2 7 233.3 23 Ramipril 87333-19-5 7 233.3 24 Ranolazine 95635-55-5 10 333.3 25 Sevelamir HCl 152751-57-0 29 966.67 26 Sparfloxacin 110871-86-8 20 666.7 27 Telapravir 402957-28-2 5 166.7 28 Ticagrelor 274693-27-5 1 33.3 29 Tramadol HCl 27203-92-5 12 400 30 Valacyclovir 124832-27-5 6 200 31 Valagancyclovir HCl 175865-59-5 2 66.7 32 Abiraterone Acetate 154229-18-2 1 33.3 33 Anastrozole 120511-73-1 2 66.7 7-3 Team Labs and Consultants Dasami Lab Pvt. Ltd. Environmental Impact Assessment Report 34 Bendamustine Hydochloride 3543-75-7 2.5 83.3 35 Bexarotene 153559-49-0 3 100 36 Bicalutamide 90357-06-5 5 166.7 37 Bortezomib 179324-69-7 0.5 16.7 38 Carboplatin 41575-94-4 5 166.7 39 Capecitabine 154361-50-9 2 66.7 40 Cisplatin 15663-27-1 2 66.7 41 Cyclophosphamide 50-18-0 2 66.7 42 Dasatinib 302962-49-8 2 66.7 43 Emtricitabine 143491-57-0 30 1000 44 Erlotinib HCl 183319-69-9 4 133.3 45 Gefitinib 184475-35-2 2 66.7 46 Gemcitabine HCl 122111-03-9 1 33.3 47 Imatinib Mesylate 220127-57-1 16 533.3 48 Irinotecan HCl 136572-09-3 14 466.7 49 Lapatinib Ditosylate Monohydrate 388082-78-8 2 66.7 50 Letrozole 112809-51-5 2.5 83.3 51 Nilotinib HCl 923288-90-8 2 66.7 52 Oxaliplatin 63121-00-6 4 133.3 53 Pazopanib Hydrchloride 635702-64-6 2 66.7 54 Pemetrexed Disodium 150399-23-8 0.5 16.7 55 Sorafenib Tosylate 475207-59-1 6 200 56 Temozolomide 85622-93-1 1 33.3 57 Sunitinib Malate 341031-54-7 6 200 Total 421 Total - Worst Case 27 Products on campaign basis 11566.7 Table 7.2 List of By-products – After Expansion S. No Name of Product Stage Name of By Product Quantity (Kg/day) 1 Amlodipine Besylate I Phthalic acid 195.2 2 Clopidogrel Hydrogen Sulphate I p-Toluene sulfonic acid 170.8 Tarataric acid 149 3 Duloxetine HCl I Sodium Phenyl Carbonate 239.9 Ethyl Acetate 131.9 4 Emtricitabine I Triethyl amine HCl 409.7 7-4 Team Labs and Consultants Dasami Lab Pvt. Ltd. Environmental Impact Assessment Report Table 7.3 List of Raw Materials and Inventory (Terms of Reference No. 3(iv) & (3(v)) S.No Name of the Raw Material Maximum Physical Type of Hazard Mode of Mode of storage Form Storage Transport (Kgs) 1 (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine 192 Solid Corrosive Bags By Road mandalic acid salt 2 (1R,2S,5S)-6,6-Dimethyl-3-aza 693 Solid Corrosive Bags By Road bicyclo [3.1.0]hexane-2-carboxylic acid methyl ester hydrochloride 3 (1S,3aS,6aS)-ethyloctahydropentalenecarboxylate 645 Powder Flammable Bags By Road 4 (2-Thienyl)ethylpara-toulene sulphonate 2247 Solid Irritant Bags By Road 5 (3S)-3-amino-N-cyclopropyl-2-hydroxyl hexanamide 426 Crystalline Corrosive Bags By Road 6 (4,6-Dichloro-2-(propylsulfanyl)-5-pyrimidinamine 164 Solid Irritant Bags By Road 7 (5R-cis)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1- 1498 Crystalline Irritant Bags By Road ylmethyl)tetrahydrofuran-3-methanol tosylate ester 8 (S)-1-(3-Ethoxy-4-methoxyphenyl)-2- 1009 Solid Corrosive Bags By Road (methylsulfonyl)ethan-1-amine acetyl-L-leucinate 9 (S)-2-((S)-2-cyclohexyl-2-(pyrazine-2- 1325 Solid Corrosive Bags By Road carboxamide)acetamido)-3,3-dimethylbutanoic acid 10 (S)-N-Methyl-N-phenyloxycarbonyl-3-(1-napthyloxy)- 5149 Solid Flammable Bags By Road 3-(2-thienyl)propylamine 11 [1,4]bipiperidinyl-1-carbonyl chloride hydrochloride 1550 Solid Corrosive Bags By Road 12 1-(2-hydroxyethyl)piperazine 218 Liquid Irritant Drums By Road 13 1(-3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC) 315 Solid corrosive Bags By Road 14 1-(6-Methoxy-2-naphthyl)-1-ethanone 2650 Powder Irritant Bags By Road 15 1,3-Dibromopropane 364 Liquid Flammable Drums By Road 16 1,3-Dicyclohexyl carbodiimide 105 Solid Irritant Bags By Road 17 10 % Brine Solution 1575 Liquid Corrosive Drums By Road 18 1-Bromodecane 770 Liquid Toxic Drums By Road 19 1-Hydroxybenzotriazole 975 solid Flammable Bags By Road 20 1-Hydroxysuccinimide 35 Solid Non hazard Bags By Road 21 1R,2R(-)1,2-Diaminocyclohexane 498 Crystalline Corrosive Bags By Road 22 2(1S)-(1S,2S,3R,5S)-pinanediol-1-ammonium 237 Powder Flammable Bags By Road 7-5 Team Labs and Consultants Dasami Lab Pvt.
Load more

Recommended publications
  • Chemical Structures of Lignans and Neolignans Isolated from Lauraceae
    Review Chemical Structures of Lignans and Neolignans Isolated from Lauraceae Ya Li 1,*, Shuhan Xie 2, Jinchuan Ying 1, Wenjun Wei 1 and Kun Gao 1,* 1 State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China; yingjch16@lzu.edu.cn (J.Y.); weiwj14@lzu.edu.cn (W.W.) 2 Lanzhou University High School, Lanzhou 730000, China; xieshzb@163.com * Correspondences: liea@lzu.edu.cn (Y.L.); npchem@lzu.edu.cn (K.G.); Tel.: +86-931-8912500 (Y.L.) Academic Editor: David Barker Received: 09 November 2018; Accepted: 29 November 2018; Published: 30 November 2018 Abstract: Lauraceae is a good source of lignans and neolignans, which are the most chemotaxonomic characteristics of many species of the family. This review describes 270 naturally occurring lignans and neolignans isolated from Lauraceae. Keywords: lignans; neolignans; Lauraceae; chemical components; chemical structures 1. Introduction Lignans are widely distributed in the plant kingdom, and show diverse pharmacological properties and a great number of structural possibilities. The Lauraceae family, especially the genera of Machilus, Ocotea, and Nectandra, is a rich source of lignans and neolignans, and neolignans represent potential chemotaxonomic significance in the study of the Lauraceae. Lignans and neolignans are dimers of phenylpropane, and conventionally classified into three classes: lignans, neolignans, and oxyneolignans, based on the character of the C–C bond and oxygen bridge joining the two typical phenyl propane units that make up their general structures [1]. Usually, lignans show dimeric structures formed by a β,β’-linkage (8,8’-linkage) between two phenylpropanes units. Meanwhile, the two phenylpropanes units are connected through a carbon–carbon bond, except for the 8,8’-linkage, which gives rise to neolignans.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,713,449 B2 Adachi Et Al
    USOO7713449B2 (12) United States Patent (10) Patent No.: US 7,713,449 B2 Adachi et al. (45) Date of Patent: May 11, 2010 (54) POLYMERELECTROLYTIC MATERIAL 6,447,943 B1* 9/2002 Peled et al. ................... 429/33 POLYMERELECTROLYTIC PART, 6,773,844 B2 8/2004 Nakano et al. MEMBRANEELECTRODE ASSEMBLY, AND 6,794,480 B2 9, 2004 Goto et al. POLYMERELECTROLYTE FUEL CELL 6,828,353 B1* 12/2004 Charnocket al. ............. 521/27 2002fOO45085 A1* 4/2002 Formato et al. ............... 429/33 (75) Inventors: Shinya Adachi, Ritto (JP); Daisuke 2002fOO91225 A1 7/2002 McGrath et al. IZuhara, Otsu (JP); Masataka 2008.0075999 A1 3/2008 Izuchara et al. Nakamura, Otsu (JP); Nobuaki Ito, Otsu (JP) (73) Assignee: Toray Industries, Inc., Chuo-ku, Tokyo FOREIGN PATENT DOCUMENTS (JP) JP 53-26777 3, 1978 (*) Notice: Subject to any disclaimer, the term of this JP 56-34329 8, 1981 patent is extended or adjusted under 35 JP 64-22932 1, 1989 U.S.C. 154(b) by 1215 days. JP 5-271460 10, 1993 JP 8-180891 T 1996 (21) Appl. No.: 10/548,110 JP 10-340732 12/1998 (22) PCT Filed: Mar. 5, 2004 JP 2-208322 3, 2000 JP 2001-504636 4/2001 (86). PCT No.: PCT/UP2004/OO2894 JP 2001-192531 T 2001 JP 2001-294705 10, 2001 S371 (c)(1), JP 2001-294.706 10, 2001 (2), (4) Date: Sep. 6, 2005 JP 2002-110200 4/2002 JP 2002-226575 8, 2002 (87) PCT Pub. No.: WO2004/0798.44 JP 2002-524.631 8, 2002 PCT Pub. Date: Sep.
    [Show full text]
  • 1.25 Lignans: Biosynthesis and Function
    1.25 Lignans: Biosynthesis and Function NORMAN G. LEWIS and LAURENCE B. DAVIN Washington State University, Pullman, WA, USA 0[14[0 INTRODUCTION 539 0[14[1 DEFINITION AND NOMENCLATURE 539 0[14[2 EVOLUTION OF THE LIGNAN PATHWAY 531 0[14[3 OCCURRENCE 534 0[14[3[0 Li`nans in {{Early|| Land Plants 534 0[14[3[1 Li`nans in Gymnosperms and An`iosperms "General Features# 536 0[14[4 OPTICAL ACTIVITY OF LIGNAN SKELETAL TYPES AND LIMITATIONS TO THE FREE RADICAL RANDOM COUPLING HYPOTHESIS 536 0[14[5 707? STEREOSELECTIVE COUPLING] DIRIGENT PROTEINS AND E!CONIFERYL ALCOHOL RADICALS 541 0[14[5[0 Diri`ent Proteins Stipulate Stereoselective Outcome of E!Coniferyl Alcohol Radical Couplin` in Pinoresinol Formation 541 0[14[5[1 Clonin` of the Gene Encodin` the Diri`ent Protein and Recombinant Protein Expression in Heterolo`ous Systems 543 0[14[5[2 Sequence Homolo`y Comparisons 543 0[14[5[3 Comparable Systems 543 0[14[5[4 Perceived Biochemical Mechanism of Action 546 0[14[6 PINORESINOL METABOLISM AND ASSOCIATED METABOLIC PROCESSES 547 0[14[6[0 Sesamum indicum] "¦#!Piperitol\ "¦#!Sesamin\ and "¦#!Sesamolinol Synthases 547 0[14[6[1 Magnolia kobus] Pinoresinol and Pinoresinol Monomethyl Ether O!Methyltransferase"s# 550 0[14[6[2 Forsythia intermedia and Forsythia suspensa 551 0[14[6[2[0 "¦#!Pinoresinol:"¦#!lariciresinol reductase 552 0[14[6[2[1 "−#!Secoisolariciresinol dehydro`enase 554 0[14[6[2[2 Matairesinol O!methyltransferase 556 0[14[6[3 Linum usitatissimum] "−#!Pinoresinol:"−#!Lariciresinol Reductase and "¦#!Secoisolariciresinol Glucosyltransferase"s# 557
    [Show full text]
  • 1.23 Lignans (Neolignans) and Allyl/Propenyl Phenols: Biogenesis, Structural Biology, and Biological/Human Health Considerations Daniel G
    1.23 Lignans (Neolignans) and Allyl/Propenyl Phenols: Biogenesis, Structural Biology, and Biological/Human Health Considerations Daniel G. Vassa˜ o, Kye-Won Kim, Laurence B. Davin, and Norman G. Lewis, Washington State University, Pullman, WA, USA ª 2010 Elsevier Ltd. All rights reserved. 1.23.1 Introduction 817 1.23.2 Definition and Nomenclature 818 1.23.2.1 Allyl-/Propenylphenols 818 1.23.2.2 Inconsistencies in Current Nomenclature of Lignans and Neolignans 818 1.23.3 Chemotaxonomical Diversity: Evolutionary Considerations 821 1.23.3.1 Allyl-/Propenylphenols and Their Derivatives 821 1.23.3.1.1 Algae 821 1.23.3.1.2 Bryophytes: liverworts, hornworts, and mosses 825 1.23.3.1.3 Pteridophytes: lycophytes, horsetails, and ferns 826 1.23.3.1.4 Spermatophytes: gymnosperms and angiosperms 826 1.23.3.2 Lignans 830 1.23.3.2.1 Bryophytes: liverworts, hornworts, and mosses 830 1.23.3.2.2 Pteridophytes: lycophytes, horsetails, and ferns 833 1.23.3.2.3 Spermatophytes: gymnosperms and angiosperms 836 1.23.3.3 Evolution of Biochemical Pathways to Allyl-/Propenylphenols and Lignans: Observations on Co-occurrence 845 1.23.4 Lignan Early Biosynthetic Steps: 8–89 Phenylpropanoid Coupling 847 1.23.4.1 Discovery of the (þ)-Pinoresinol-Forming Dirigent Protein and Encoding Gene 847 1.23.4.2 Western Red Cedar Dirigent Proteins 849 1.23.4.3 Structural and Mechanistic Studies 849 1.23.4.4 Discovery of the (À)-Pinoresinol-Forming Dirigent Protein and Encoding Gene 849 1.23.4.5 Dirigent Protein Tissue Localization and Metabolic Networks 851 1.23.4.5.1 mRNA tissue
    [Show full text]
  • Solid Phase Synthesis of Graft Copolymers of Poly(Thiophene)S and Peptides Containing 3-Thienylalanine
    University of Massachusetts Amherst ScholarWorks@UMass Amherst Doctoral Dissertations 1896 - February 2014 1-1-2004 Solid phase synthesis of graft copolymers of poly(thiophene)s and peptides containing 3-thienylalanine. David W. Flanagan University of Massachusetts Amherst Follow this and additional works at: https://scholarworks.umass.edu/dissertations_1 Recommended Citation Flanagan, David W., "Solid phase synthesis of graft opoc lymers of poly(thiophene)s and peptides containing 3-thienylalanine." (2004). Doctoral Dissertations 1896 - February 2014. 1062. https://scholarworks.umass.edu/dissertations_1/1062 This Open Access Dissertation is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in Doctoral Dissertations 1896 - February 2014 by an authorized administrator of ScholarWorks@UMass Amherst. For more information, please contact scholarworks@library.umass.edu. SOLID PHASE SYNTHESIS OF GRAFT COPOLYMERS OF POLY(THIOPHENE)S AND PEPTIDES CONTAINING 3-THIENYLALANINE A Dissertation Presented by DAVID W. FLANAGAN Submitted to the Graduate School of the University of Massachusetts Amherst in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY September 2004 Polymer Science and Engineering © Copyright by David W. Flanagan 2004 All Rights Reserved SOLID PHASE SYNTHESIS OF GRAFT COPOLYMERS OF POLY(THIOPHENE)S AND PEPTIDES CONTAINING 3-THIENYLALANINE A Dissertation Presented by DAVID W. FLANAGAN Approved^slo style and content by: David JrGross, Member Shawv L. Hsu, Member Shaw L. Hsu, Department Chair Polymer Science and Engineering / am in blood Stepp'd in so far that, should I wade no more, Returning were as tedious as go o'er. Macbeth (III.iv.136-138) Acknowledgments Distilling the work of a graduate career into about 100 cubic inches of paper requires one to reflect upon the experiments performed, the data collected, and the conclusions reached.
    [Show full text]
  • Essential Oils and Nanotechnology for Treatment of Microbial Diseases
    Essential Oils and Nanotechnology for Treatment of Microbial Diseases Essential Oils and Nanotechnology for Treatment of Microbial Diseases Editors Mahendra Rai Department of Biotechnology Sant Gadge Baba Amravati University Amravati Maharashtra India Susana Zacchino Area Farmacognosia Facultad de Ciencias Bioquímicas y Farmacéuticas Universidad Nacional de Rosario Rosario (Santa Fe) Argentina Marcos G. Derita Area Farmacognosia Facultad de Ciencias Bioquímicas y Farmacéuticas Universidad Nacional de Rosario Rosario (Santa Fe) Argentina and CONICET Cátedra de Cultivos Intensivos Facultad de Ciencias Agrarias Universidad Nacional del Litoral Esperanza (Santa Fe) Argentina p, p, A SCIENCE PUBLISHERS BOOK A SCIENCE PUBLISHERS BOOK Cover illustrations: Top right image: Antibacterial mechanism of nanoparticles. Figure 9.1 from Chapter 9. Reproduced by kind courtesy of Dr. Mahendra Rai (book editor/chapter author). Bottom left image: Antimicrobial strategies in anti-infectious coatings. Figure 10.1 from Chapter 10. Reproduced by kind courtesy of Dr. Juan Bueno (chapter author). CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2018 by Taylor & Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Printed on acid-free paper Version date is 20170724 International Standard Book Number-13: 978-1-1386-3072-7 (Hardback) This book contains information obtained from authentic and highly regarded sources. Reasonable efforts have been made to publish reliable data and information, but the author and publisher cannot assume responsibility for the validity of all materials or the consequences of their use. The authors and publishers have attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form has not been obtained.
    [Show full text]
  • Evaluation of the Status Quo of Polyphenols Analysis: Part I—Phytochemistry, Bioactivity, Interactions, and Industrial Uses
    Received: 16 January 2020 Revised: 11 July 2020 Accepted: 28 July 2020 DOI: 10.1111/1541-4337.12629 COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY Evaluation of the status quo of polyphenols analysis: Part I—phytochemistry, bioactivity, interactions, and industrial uses Ana Sanches Silva1,2 Patricia Reboredo-Rodríguez3 Ipek Süntar4 Antoni Sureda5 Tarun Belwal6 Monica Rosa Loizzo7 Rosa Tundis7 Eduardo Sobarzo-Sanchez8,9 Luca Rastrelli10,11 Tamara Y. Forbes-Hernandez12 Maurizio Battino12,13,14 Rosanna Filosa11 Maria Daglia11,15 Seyed Fazel Nabavi16 Seyed Mohammad Nabavi16 1 National Institute for Agricultural and Veterinary Research (INIAV), I.P., Vairão, Vila do Conde, Portugal 2 Center for Study in Animal Science (CECA), University of Oporto, Oporto, Portugal 3 Nutrition and Bromatology Group, Department of Analytical and Food Chemistry, CITACA, Faculty of Science, University of Vigo – Ourense Campus, Ourense E32004, Spain 4 Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, Ankara, Turkey 5 Research Group on Community Nutrition and Oxidative Stress (NUCOX), Health Research Institute of Balearic Islands (IdISBa) and CIBEROBN (Physiopathology of Obesity and Nutrition CB12/03/30038), University of Balearic Islands, Palma de Mallorca, Balearic Islands, Spain 6 College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, Zhejiang, China 7 Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende, Italy 8 Laboratory of Pharmaceutical Chemistry, Faculty of
    [Show full text]
  • Tumor Inhibitors. 126. New Cytotoxic Neolignans from Aniba Megaphylla
    586 J. Org. Chem., Vol. 43, No. 4, 1978 Kupchan et al. New Cytotoxic Neolignans from Aniba megaphylla Mez.1*2 S. Morris IK~pchan,~Kenneth L. Stevens,*4Eric A. Rohlfing, Barry R. Sickles, Albert T. Sneden,* Richard W. Miller, and Robert F. Bryan* Department of Chemistry, Uniuersity of Virginia, Charlottesuille, Virginia 22901 Received June 30,1977 The isolation and elucidation of the structure and stereochemistry of megaphone (l),a new cytotoxic neolignan from Aniba rnegaphylla Mez., are reported. Chemical and spectral evidence supported structure 1 for megaphone, and a direct x-ray crystallographic analysis confirmed the structure and established the stereochemistry. Two addi- tional new cytotoxic neolignans, megaphone acetate (2) and megaphyllone acetate (3), were isolated and their struc- tures deduced in light of the structure of 1. The lack of activity of these neolignans as inhibitors of mitosis in sea ur- chin eggs is discussed in terms of structural features. An alcoholic extract of Aniba megaphylla Mez. (Laura- Chart I. Fractionation of the Cytotoxic Extract from ceae)5 was found to demonstrate inhibitory activity in vitro Aniba megaphylla Mez. against cells derived from human carcinoma of the naso- dried ground roots of A. meqaphylla (1 kg) pharynx (KB)? Systematic fractionation of the active ethanol I extract (Chart I) guided by KB activity led to the isolation of I hot 95% ethanol extraction three new cytotoxic neolignans, megaphone (l),megaphone acetate (2), and megaphyllone acetate (3). ethanolic extract A (81.3 4) partition between water and chloroform chl oroforrrI so 1 u bl e water soluble fraction C (50.5 g) fraction B (12.2 9) I We partition between H,OIMethanol (1:9) 1, P= '- 1 and Skellysolve B 3 2_.
    [Show full text]